Exabis Library
Welcome to the e-CCO Library!
P396: COVID-19 pandemic-related endoscopy delays did not translate to deleterious outcomes for patients with Inflammatory Bowel Disease: A retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P396: Cyclosporin A efficacy in a paediatric ulcerative colitis: a retrospective single-centre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P396: Long-term efficacy of thiopurines as maintenance treatment in 130 patients with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P396: Monitoring adalimumab compliance using smart sharp bin technology
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P396: Pharmacokinetics, immunogenicity and clinical outcomes of golimumab from the PURSUIT PEDS ulcerative colitis study long-term (through week 126) extension
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P396: Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P397 Surveillance in ulcerative colitis: Can we predict the risk for intraepithelial neoplasia?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P397: Advanced therapy persistence and need for dose optimisation in a cohort of Inflammatory Bowel Disease patients in Argentina: a real-world evidence multicenter study (REMAR study)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P397: Approach and management of psychological aspects of inflammatory bowel disease described by patients and physicians in Spain. The ENMENTE Project
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P397: Autologous stem cell transplantation in refractory Crohn's disease: evaluation of a modified mobilisation regimen and analyses of the cost-effectiveness
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P397: Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P397: Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P397: Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P397: Response to biologics in IBD patients assessed by Computerized image analysis of Probe Based Confocal Laser Endomicroscopy with molecular labeling
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P398 The early appearance of anti-drug antibodies during the induction phase predicts the clinical response of adalimumab and infliximab in IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P398: An objective measure of response to treatment for patients with Crohn's perianal fistulas on anti-TNF treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P398: Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P398: Disease clearance: a potential target for management of patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P398: Effect of Intravenous versus Oral Iron Therapy on Physical Fitness and Haemoglobin in Paediatric IBD Patients with Anaemia
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P398: Leptin controls immune cell composition and activity in acquired generalised lipodystrophy with combined Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM